Collagen dysregulation in the dermis of the Sagg/+ mouse:: A loose skin model

被引:12
作者
Christner, Paul J.
Gentiletti, Julieta
Peters, Josephine
Ball, Simon T.
Yamauchi, Mitsuo
Atsawasuwan, Phimon
Beason, David P.
Soslowsky, Louis J.
Birk, David E.
机构
[1] Thomas Jefferson Univ, Div Rheumatol, Dept Med, Philadelphia, PA 19107 USA
[2] MRC, Mammalian Genet Unit, Harwell, Oxon, England
[3] Univ N Carolina, Dent Res Ctr, Chapel Hill, NC USA
[4] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA
[5] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
基金
英国医学研究理事会;
关键词
D O I
10.1038/sj.jid.5700100
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The Sagg/+ mouse is an ethylnitrosourea-derived mutant with a dermal phenotype similar to some of the subtypes of Ehlers-Danlos syndrome (EDS) and cutis laxa. The dermis of the Sagg/+ mouse has less dense and more disorganized collagen fibers compared to controls. The size of extracted Type I dermal collagen was the same as that observed in normal skin; however, more collagen could be extracted from Sagg/+ skin, which also showed decreased collagen content and decreased steady-state levels of alpha 1(I), alpha 2(I), alpha 1(V), and a 2(V) procollagen mRNAs. The biomechanical properties of Sagg/+ skin were significantly decreased relative to normal skin. However, there were no significant differences in the quantities of the major collagen cross-links, that is, dehydrohydroxylysinonorleucine and dehydrohistidinohydroxymerodesmosine between Sagg/+ and normal skin. Electron microscopic evaluation of Sagg/+ skin indicated that the mutation interferes with the proper formation of collagen fibrils and the data are consistent with a mutation in Type V collagen leading to haploinsufficiency with the formation of two sub-populations of collagen fibrils, one normal and one with irregular shape and a larger diameter. Further study of this novel mutation will allow the identification of new mechanisms involved in the regulation of normal and pathologic collagen gene expression.
引用
收藏
页码:595 / 602
页数:8
相关论文
共 67 条
[61]  
Yamamoto K, 1999, BRIT J DERMATOL, V141, P667
[62]  
YAMAUCHI M, 1987, J BIOL CHEM, V262, P11428
[63]  
Yamauchi Mitsuo, 2002, Methods Mol Biol, V194, P277
[64]   Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI [J].
Yeowell, HN ;
Walker, LC .
MOLECULAR GENETICS AND METABOLISM, 2000, 71 (1-2) :212-224
[65]  
Zlotogora J, 1999, AM J MED GENET, V85, P194, DOI 10.1002/(SICI)1096-8628(19990716)85:2<194::AID-AJMG19>3.0.CO
[66]  
2-P
[67]   Joint hypermobility syndromes - The pathophysiologic role of tenascin-x gene defects [J].
Zweers, MC ;
Hakim, AJ ;
Grahame, R ;
Schalkwijk, J .
ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :2742-2749